A hypnotherapy app for IBS helped patients. It could not prove it matched a therapist

Gut-directed hypnotherapy — a structured course of relaxation and gut-focused suggestion — is a recommended treatment for irritable bowel syndrome, but a trained therapist is expensive and often unavailable, so several companies now deliver it as a self-guided smartphone app. A multicentre randomised trial set out to test whether the app version works as well as the human one, and could not show that it does: the app produced an abdominal-pain response in 33% of patients, against 48% for in-person therapist-delivered hypnotherapy and 22% for online psychoeducation [s1]. The app clearly beat education alone, but it fell short of the pre-set bar for matching a therapist.

What the trial did

The three-armed trial, published in Gut, enrolled 230 adults meeting the Rome IV criteria for IBS (ages 16–75, 70.4% female, mean age 38.2) and randomised them to 12 weeks of one of three interventions: in-person therapist-delivered hypnotherapy, self-guided hypnotherapy through a smartphone app, or online self-guided psychoeducation as the control [s1]. The primary endpoint used the US Food and Drug Administration's definition of an abdominal-pain responder — at least a 30% reduction from baseline in the weekly average of worst daily pain, in at least two of four follow-up weeks [s1]. This was a non-inferiority trial, meaning the app was not asked to beat the therapist, only to come within a pre-specified margin of 10 percentage points [s1].

The result

It did not clear that margin. The difference between the app and in-person hypnotherapy was −14.7 percentage points, with a 95% confidence interval of −29.3 to 0.9 [s1]. Because the lower bound sits well past the −10 margin, non-inferiority could not be declared — the app might be nearly as good, or it might be substantially worse, and the trial could not rule the latter out. In-person hypnotherapy, by contrast, clearly outperformed psychoeducation at week 16 (odds ratio 3.48, 95% CI 1.68–7.20, p<0.001) [s1].

Two findings complicate a simple "the app lost" reading. First, by the six-month follow-up both hypnotherapy arms — app included — were significantly better than education (odds ratios 3.11 and 4.68, p=0.007 and p<0.001), suggesting the app's benefit was durable even if it started lower [s1]. Second, none of the arms moved patients' psychological symptom scores, so the pain benefit did not run through measured anxiety or depression [s1]. A 33% response to a fully self-guided app, against 22% for a credible control, is not nothing — it is roughly the effect size seen for several accepted IBS therapies.

How it fits the wider evidence

That context comes from a network meta-analysis of 67 randomised trials and 7,441 patients, which confirms brain-gut behaviour therapies including gut-directed hypnotherapy and IBS-specific cognitive behavioural therapy among the effective options and notes that digital delivery is an increasingly studied route [s2]. The therapist-delivered result here is consistent with that body of work; the open question the trial sharpens is how much of the effect survives when the therapist is removed and replaced by an app.

"Non-inferiority not shown" is not the same as "does not work," and the distinction is where digital therapeutics are routinely oversold. The honest summary is that the app helped, helped less than a person, and could not be proven equivalent — which is a stronger evidence base than most cleared digital therapeutics carry, and a useful counter to the gap between what "cleared" implies and what a product does. It sits alongside other randomised tests of app-delivered therapy where the effect is real but smaller than the marketing, and where regulators have flagged thin evidence behind digital mental-health tools.

What to watch

Whether the app is positioned as a therapist substitute or a first step. As a way to reach the many IBS patients who will never see a hypnotherapist, a self-guided app with a durable 33% response is a plausible, low-cost option [s1]. As a claimed equal to in-person care, this trial says the evidence is not there. The access argument is real; the equivalence claim is the one to read sceptically.

This article is informational and is not medical advice.

Sources

• [s1] "In-person therapist-delivered hypnotherapy versus smartphone-based self-guided hypnotherapy in IBS: a multicentre three-armed randomised controlled trial." Gut, published online 25 July 2026. Trial registration NCT03899779. https://doi.org/10.1136/gutjnl-2026-338385
• [s2] "Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis." The Lancet Gastroenterology & Hepatology, published online 10 October 2025. https://doi.org/10.1016/S2468-1253(25)00238-9